Dealmaking Quarterly Statistics, Q4 2020
A Look At M&A And Alliance Activity Across Medical Device And In Vitro Diagnostics Industries, October-December 2020
Executive Summary
During Q4, medical device company M&A values reached $5.7bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $3.3bn.
You may also be interested in...
SeaSpine Holdings Acquires Toronto-Based 7D Surgical For $110M
BTIG analyst expects SeaSpine’s acquisition of 7D Systems will help SeaSpine morph into a procedurally integrated solutions provider.
Roche Buys GenMark Diagnostics For $1.8Bn
GenMark’s syndromic panel testing portfolio complements Roche’s molecular diagnostics business.
Veracyte Expands Into Urologic Cancer Testing By Acquiring Decipher For $600M
With the addition of Decipher, Veracyte now offers tests for seven of the 10 most common types of cancer in the US.